Contineum Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 9.39 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 353.26M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The company’s lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and chronic pain. It also develops PIPE-307, a novel, small-molecule inhibitor of the muscarinic type 1 receptor for depression and relapse-remitting multiple sclerosis. The company was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. Contineum Therapeutics, Inc. was incorporated in 2009 and is based in San Diego, California.
Details
| Name | Contineum Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 51 |
| Founded | 2009 |
| Ipo Date | 2024-04-05 |
| Ceo | Carmine Stengone |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 16.00 |
| Isin | US21217B1008 |
| Cusip | 21217B100 |
| Cik | 1855175 |
| Sic | 2834 |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
Key executives
| Name | Title |
|---|---|
| Carmine N. Stengone MBA, MS | President, Chief Executive Officer and Director |
| Peter T. Slover CPA | Chief Financial Officer |
| Dr. Timothy R. Watkins M.D., M.Sc. | Chief Medical Officer and Head of Development |
| Morgan Paulsen | Senior Manager of Accounting |
| Dr. Daniel S. Lorrain Ph.D. | Chief Science Officer |
| Steve E. Kunszabo | Senior Director of Investor Relations and Corporate Communications |
| John S. Healy | General Counsel and Corporate Secretary |
| Austin Chen Ph.D. | Senior Vice President and Head of Research |
| Julie S. Iwashita | Senior Vice President of Clinical Operations |
| Kristina Haeckl Rac | Senior Vice President of Regulatory Affairs |
Contact
| Address | 3565 General Atomics Court, Suite 200, San Diego, California 92121, United States |
| Phone | 858 333 5280 |
| Website | https://www.contineum-tx.com |